• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

Public
GLUE
United States
SectorHealthcare
CountryUnited States
Market cap150.09M
A clinical-stage biopharmaceutical company developing treatments for galectin-mediated diseases.

Where to buy Galectin Therapeutics Inc. (GLUE)

GLUE trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare